Common use of Common Interest Clause in Contracts

Common Interest. All information exchanged between the Parties regarding the Prosecution and Maintenance, and enforcement and defense, of the Patent Rights under this Article 10 (Intellectual Property) will be deemed Confidential Information of the disclosing Party. In addition, the Parties acknowledge and agree that, with regard to such Prosecution and Maintenance, and enforcement and defense of the Patent Rights under this Article 10 (Intellectual Property), the interests of the Parties as collaborators and licensor and licensee are to obtain the strongest patent protection possible, and as such, are aligned and are legal in nature. The Parties agree and acknowledge that they have not waived, and nothing in this Agreement constitutes a waiver of, any legal privilege concerning the Patent Rights under this Article 10 (Intellectual Property), including privilege under the common interest doctrine and similar or related doctrines. Notwithstanding anything to the contrary contained herein, to the extent a Party has a good faith belief that any information required to be disclosed by such Party to the other Party under this Article 10 (Intellectual Property) is protected by attorney-client privilege or any other applicable legal privilege or immunity, such Party will not be required to disclose such information and the Parties will in good faith cooperate to agree upon a procedure (including entering into a specific common interest agreement, disclosing such information on a “for counsel eyes only” basis or similar procedure) under which such information may be disclosed without waiving or breaching such privilege or immunity.

Appears in 2 contracts

Samples: Collaboration and License Agreement (Metagenomi Technologies, LLC), Collaboration and License Agreement (Ionis Pharmaceuticals Inc)

AutoNDA by SimpleDocs

Common Interest. All information exchanged between the Parties regarding the Prosecution and Maintenanceprosecution, and maintenance, enforcement and defense, defense of the Patent Rights Patents under this Article 10 (Intellectual Property) ARTICLE 7 will be deemed to be Confidential Information of the disclosing Party. In addition, the Parties acknowledge and agree that, with regard to such Prosecution and Maintenanceprosecution, and maintenance, enforcement and defense of the Patent Rights under this Article 10 (Intellectual Property)defense, the interests of the Parties as collaborators and licensor and licensee are collaborators, licensors and/or licensees are, for their mutual benefit, to obtain the strongest patent protection possibleand plan patent defense against potential patentability/invalidity challenges or infringement activities by Third Parties, and as such, are aligned and are legal in nature. The Parties agree and acknowledge that they have not waived, and nothing in this Agreement constitutes a waiver of, any legal privilege concerning the Patent Rights Patents under this Article 10 (Intellectual Property)ARTICLE 7, including privilege under the common interest doctrine and similar or related doctrines. Notwithstanding anything to the contrary contained hereinin this Agreement, to the extent a Party has a good faith belief that any information required to be disclosed by such Party to the other Party under this Article 10 (Intellectual Property) ARTICLE 7 is protected by attorney-client privilege or any other applicable legal privilege or immunity, such Party will shall not be required to disclose such information and the Parties will shall in good faith cooperate to agree upon a procedure (including which may include entering into a specific common interest agreement, disclosing such information on a “for counsel eyes only” basis or similar procedure) under which such information may be disclosed without waiving or breaching such privilege or immunity.

Appears in 2 contracts

Samples: Collaboration and License Agreement (Caribou Biosciences, Inc.), Collaboration and License Agreement (Caribou Biosciences, Inc.)

Common Interest. All information exchanged between the Parties regarding the Prosecution and Maintenance, and enforcement and defense, of the Patent Rights Patents under this Article 10 9 (Intellectual Property; Ownership) will be deemed Confidential Information of the disclosing Party. In addition, the Parties acknowledge and agree that, with regard to such Prosecution and Maintenance, and enforcement and defense of the Patent Rights under this Article 10 (Intellectual Property)defense, the interests of the Parties as collaborators and licensor and licensee are to obtain the strongest patent protection possible, and as such, are aligned and are legal in nature. The Parties agree and acknowledge that they have not waived, and nothing in this Agreement constitutes a waiver of, any legal privilege concerning the Patent Rights Patents under this Article 10 9 (Intellectual Property; Ownership), including privilege under the common interest doctrine and similar or related doctrines. Notwithstanding anything to the contrary contained herein, to the extent a Party has a good faith belief that any information required to be disclosed by such Party to the other Party under this Article 10 9 (Intellectual Property; Ownership) is protected by attorney-client privilege or any other applicable legal privilege or immunity, such Party will shall not be required to disclose such information and the Parties will shall in good faith cooperate to agree upon a procedure (including entering into a specific common interest agreement, disclosing such information on a “for counsel eyes only” basis or similar procedure) under which such information may be disclosed without waiving or breaching such privilege or immunity.

Appears in 1 contract

Samples: License and Collaboration Agreement (CG Oncology, Inc.)

Common Interest. All information exchanged between the Parties regarding the Prosecution and Maintenanceprosecution, and maintenance, enforcement and defense, defense of the Patent Rights Patents under this Article 10 (Intellectual Property) ARTICLE 8 will be deemed to be Confidential Information of the disclosing Party. In addition, the Parties acknowledge and agree that, with regard to such Prosecution and Maintenanceprosecution, and maintenance, enforcement and defense of the Patent Rights under this Article 10 (Intellectual Property)defense, the interests of the Parties as collaborators and licensor Harpoon and licensee are to to, for their mutual benefit, obtain the strongest patent protection possibleand plan patent defense against potential infringement activities by Third Parties, and as such, are aligned and are legal in nature. The Parties agree and acknowledge that they have not waived, and nothing in this Agreement constitutes a waiver of, any legal privilege concerning the Patent Rights Patents under this Article 10 (Intellectual Property)ARTICLE 8, including privilege under the common interest doctrine and similar or related doctrines. Notwithstanding anything to the contrary contained hereinin this Agreement, to the extent a Party has a good faith belief that any information required to be disclosed by such Party to the other Party under this Article 10 (Intellectual Property) ARTICLE 8 is protected by attorney-client privilege or any other applicable legal privilege or immunity, such Party will shall not be required to disclose such information and the Parties will shall in good faith cooperate to agree upon a procedure (including which may include entering into a specific common interest agreement, disclosing such information on a “for counsel eyes only” basis or similar procedure) under which such information may be disclosed without waiving or breaching such privilege or immunity.

Appears in 1 contract

Samples: Discovery Collaboration and License Agreement (Harpoon Therapeutics, Inc.)

Common Interest. All information Information exchanged between the Parties regarding the Prosecution and Maintenanceprosecution, and maintenance, enforcement and defense, defense of the Patent Rights Patents under this Article 10 (Intellectual Property) 11 will be deemed to be Confidential Information of the disclosing Party. In addition, the Parties acknowledge and agree that, with regard to such Prosecution and Maintenanceprosecution, and maintenance, enforcement and defense of the Patent Rights under this Article 10 (Intellectual Property)defense, the interests of the Parties as collaborators and licensor and licensee collaborators, licensors or licensees are to to, for their mutual benefit, obtain the strongest patent protection possibleand plan patent defense against potential patentability/invalidity challenges or infringement activities by Third Parties, and as such, are aligned and are legal in nature. The Parties agree Each Party agrees and acknowledge acknowledges that they have it has not waived, and nothing in this Agreement constitutes a waiver of, any legal privilege concerning the Patent Rights Patents under this Article 10 (Intellectual Property)11, including privilege under the common interest doctrine and similar or related doctrines. Notwithstanding anything to the contrary contained hereinin this Agreement, to the extent a Party has a good faith belief that any information Information required to be disclosed by such Party to the other Party under this Article 10 (Intellectual Property) 11 is protected by attorney-client privilege or any other applicable legal privilege or immunity, such Party will shall not be required to disclose such information Information and the Parties will shall in good faith cooperate to agree upon a procedure (including which may include entering into a specific common interest agreement, disclosing such information Information on a “for counsel eyes only” basis or similar procedure) under which such information Information may be disclosed without waiving or breaching such privilege or immunity.

Appears in 1 contract

Samples: License and Collaboration Agreement (I-Mab)

AutoNDA by SimpleDocs

Common Interest. All information exchanged between the Parties regarding the Prosecution and Maintenanceprosecution, maintenance, enforcement, and enforcement and defense, defense of the Patent Rights or a Patent Challenge with respect to a Third Party’s Patent Rights under this Article 10 (Intellectual Property) will be deemed the Confidential Information of the disclosing Party. In addition, the Parties acknowledge stipulate and agree that, with regard to such Prosecution and Maintenanceprosecution, maintenance, enforcement, and enforcement and defense of the Patent Rights under this Article 10 (Intellectual Property), the interests of the Parties as collaborators and licensor and licensee are to obtain the strongest patent protection possible, and as such, are aligned and are legal in nature. The Parties stipulate and agree and acknowledge that they have not waived, and nothing in this Agreement constitutes a waiver of, any legal privilege concerning the Patent Rights under this Article 10 (Intellectual Property), including privilege under the common interest doctrine and similar or related doctrines. Notwithstanding anything any provision to the contrary contained hereinset forth in this Agreement, to the extent a Party has a good faith belief that any information required to be disclosed by such Party to the other Party under this Article 10 (Intellectual Property) is protected by attorney-client privilege or any other applicable legal privilege or immunity, such Party will not be required to disclose such information and the Parties will in good faith cooperate to agree upon a procedure (including entering into a specific common interest agreement, disclosing such information on a “for counsel eyes only” basis or similar procedure) under which such information may be disclosed without waiving or breaching such privilege or immunity.

Appears in 1 contract

Samples: , and Option Agreement (Sarepta Therapeutics, Inc.)

Common Interest. All information exchanged between the Parties regarding the Prosecution and Maintenanceprosecution, and maintenance, enforcement and defense, defense of the Patent Rights Patents under this Article 10 ARTICLE 7 (Intellectual PropertyProperty Rights) will shall be deemed to be Confidential Information of the disclosing Party. In addition, the Parties acknowledge and agree that, with regard to such Prosecution and Maintenanceprosecution, and maintenance, enforcement and defense of the Patent Rights under this Article 10 (Intellectual Property)defense, the interests of the Parties as collaborators and licensor and licensee collaborators, licensors and/or licensees are to to, for their mutual benefit, obtain the strongest patent protection possibleand plan patent defense against potential patentability/invalidity challenges or infringement activities by Third Parties, and and, as such, are aligned and are legal in nature. The Parties agree and acknowledge that they have not waived, and nothing in this Agreement constitutes a waiver of, any legal privilege concerning the Patent Rights Patents under this Article 10 ARTICLE 7 (Intellectual PropertyProperty Rights), including privilege under the common interest doctrine and similar or related doctrines. Notwithstanding anything to the contrary contained hereinin this Agreement, to the extent a Party has a good faith belief that any information required to be disclosed by such Party to the other Party under this Article 10 ARTICLE 7 (Intellectual PropertyProperty Rights) is protected by attorney-client privilege or any other applicable legal privilege or immunity, such Party will shall not be required to disclose such information and the Parties will shall in good faith cooperate to agree upon a procedure (including which may include entering into a specific common interest agreement, disclosing such information on a “for counsel eyes only” basis or similar procedure) under which such information may be disclosed without waiving or breaching such privilege or immunity.

Appears in 1 contract

Samples: Option and License Agreement (Alpine Immune Sciences, Inc.)

Common Interest. All information exchanged between the Parties regarding the Prosecution and Maintenance, defense, and enforcement and defenseenforcement, of the Patent Rights under this Article 10 13 (Intellectual Property) will be deemed Confidential Information of the disclosing Party. In addition, the Parties acknowledge and agree that, with regard to such Prosecution and Maintenance, defense, and enforcement and defense of the Patent Rights under this Article 10 13 (Intellectual Property), the interests of the Parties as collaborators and licensor and licensee are to obtain the strongest patent protection possible, and as such, are aligned and are legal in nature. The Parties agree and acknowledge that they have not waived, and nothing in this Agreement constitutes a waiver of, any legal privilege concerning the Patent Rights under this Article 10 13 (Intellectual Property), including privilege under the common interest doctrine and similar or related doctrines. Notwithstanding anything any provision to the contrary contained herein, to the extent a Party has a good faith belief that any information required to be disclosed by such Party to the other Party under this Article 10 13 (Intellectual Property) is protected by attorney-client privilege or any other applicable legal privilege or immunity, such Party will not be required to disclose such information and the Parties will in good faith cooperate to agree upon a procedure (including entering into a specific common interest agreement, disclosing such information on a “for counsel eyes only” basis or similar procedure) under which such information may be disclosed without waiving or breaching such privilege or immunity.

Appears in 1 contract

Samples: Exclusive License Agreement (Neurocrine Biosciences Inc)

Time is Money Join Law Insider Premium to draft better contracts faster.